Literature DB >> 8157027

The type II collagenopathies: a spectrum of chondrodysplasias.

J Spranger1, A Winterpacht, B Zabel.   

Abstract

With the application of molecular techniques the aetiopathogenesis of skeletal dysplasias is gradually elucidated. Recent advances show that some bone dysplasias result from defects in the biosynthesis of type II (cartilage) collagen. Clinical entities caused by mutations in the COL2A1 gene coding for type II collagen comprise achondrogenesis II, hypochondrogenesis, spondyloepiphyseal dysplasia congenita, Kniest dysplasia, Stickler arthroophthalmopathy and mild dominant spondyloarthropathy. The mutations are expressed in the heterozygous state, and inheritance of type II collagenopathies is autosomal dominant. The wide range of clinical manifestations is not well understood but characterization of the basic defect may provide clues to establish specific genotype-phenotype correlations.

Entities:  

Mesh:

Year:  1994        PMID: 8157027     DOI: 10.1007/bf01959208

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  60 in total

1.  Procollagen II gene mutation in Stickler syndrome.

Authors:  D M Brown; B E Nichols; T A Weingeist; V C Sheffield; A E Kimura; E M Stone
Journal:  Arch Ophthalmol       Date:  1992-11

2.  HEREDITARY PROGRESSIVE ARTHRO-OPHTHALMOPATHY.

Authors:  G B STICKLER; P G BELAU; F J FARRELL; J D JONES; D G PUGH; A G STEINBERG; L E WARD
Journal:  Mayo Clin Proc       Date:  1965-06       Impact factor: 7.616

3.  Mild spondyloepiphyseal dysplasia (Namaqualand type): genetic linkage to the type II collagen gene COL2A1.

Authors:  C Sher; R Ramesar; R Martell; I Learmonth; P Tsipouras; P Beighton
Journal:  Am J Hum Genet       Date:  1991-03       Impact factor: 11.025

Review 4.  Seminars in medicine of the Beth Israel Hospital, Boston. Mutations in collagen genes as a cause of connective-tissue diseases.

Authors:  D J Prockop
Journal:  N Engl J Med       Date:  1992-02-20       Impact factor: 91.245

Review 5.  Heritable diseases of collagen.

Authors:  D J Prockop; K I Kivirikko
Journal:  N Engl J Med       Date:  1984-08-09       Impact factor: 91.245

6.  Identification of the molecular defect in a family with spondyloepiphyseal dysplasia.

Authors:  B Lee; H Vissing; F Ramirez; D Rogers; D Rimoin
Journal:  Science       Date:  1989-05-26       Impact factor: 47.728

7.  A mutation in the amino-terminal end of the triple helix of type II collagen causing severe osteochondrodysplasia.

Authors:  M Vikkula; P Ritvaniemi; A F Vuorio; I Kaitila; L Ala-Kokko; L Peltonen
Journal:  Genomics       Date:  1993-04       Impact factor: 5.736

Review 8.  A second mutation in the type II procollagen gene (COL2AI) causing stickler syndrome (arthro-ophthalmopathy) is also a premature termination codon.

Authors:  N N Ahmad; D M McDonald-McGinn; E H Zackai; R G Knowlton; D LaRossa; J DiMascio; D J Prockop
Journal:  Am J Hum Genet       Date:  1993-01       Impact factor: 11.025

9.  Type II collagen defect in two sibs with the Goldblatt syndrome, a chondrodysplasia with dentinogenesis imperfecta, and joint laxity.

Authors:  J Bonaventure; R Stanescu; V Stanescu; J C Allain; M P Muriel; D Ginisty; P Maroteaux
Journal:  Am J Med Genet       Date:  1992-12-01

10.  Kniest and Stickler dysplasia phenotypes caused by collagen type II gene (COL2A1) defect.

Authors:  A Winterpacht; M Hilbert; U Schwarze; S Mundlos; J Spranger; B U Zabel
Journal:  Nat Genet       Date:  1993-04       Impact factor: 38.330

View more
  49 in total

1.  Splicing mutations of 54-bp exons in the COL11A1 gene cause Marshall syndrome, but other mutations cause overlapping Marshall/Stickler phenotypes.

Authors:  S Annunen; J Körkkö; M Czarny; M L Warman; H G Brunner; H Kääriäinen; J B Mulliken; L Tranebjaerg; D G Brooks; G F Cox; J R Cruysberg; M A Curtis; S L Davenport; C A Friedrich; I Kaitila; M R Krawczynski; A Latos-Bielenska; S Mukai; B R Olsen; N Shinno; M Somer; M Vikkula; J Zlotogora; D J Prockop; L Ala-Kokko
Journal:  Am J Hum Genet       Date:  1999-10       Impact factor: 11.025

Review 2.  Changes in clinical practice with the unravelling of diseases: connective-tissue disorders.

Authors:  J Spranger
Journal:  J Inherit Metab Dis       Date:  2001-04       Impact factor: 4.982

Review 3.  Progressive pseudorheumatoid dysplasia: report of a family and review.

Authors:  H E el-Shanti; H Z Omari; H I Qubain
Journal:  J Med Genet       Date:  1997-07       Impact factor: 6.318

Review 4.  The p63 gene in EEC and other syndromes.

Authors:  H G Brunner; B C J Hamel; H Van Bokhoven
Journal:  J Med Genet       Date:  2002-06       Impact factor: 6.318

5.  Stickler syndrome caused by COL2A1 mutations: genotype-phenotype correlation in a series of 100 patients.

Authors:  Kristien P Hoornaert; Inge Vereecke; Chantal Dewinter; Thomas Rosenberg; Frits A Beemer; Jules G Leroy; Laila Bendix; Erik Björck; Maryse Bonduelle; Odile Boute; Valerie Cormier-Daire; Christine De Die-Smulders; Anne Dieux-Coeslier; Hélène Dollfus; Mariet Elting; Andrew Green; Veronica I Guerci; Raoul C M Hennekam; Yvonne Hilhorts-Hofstee; Muriel Holder; Carel Hoyng; Kristi J Jones; Dragana Josifova; Ilkka Kaitila; Suzanne Kjaergaard; Yolande H Kroes; Kristina Lagerstedt; Melissa Lees; Martine Lemerrer; Cinzia Magnani; Carlo Marcelis; Loreto Martorell; Michèle Mathieu; Meriel McEntagart; Angela Mendicino; Jenny Morton; Gabrielli Orazio; Véronique Paquis; Orit Reish; Kalle O J Simola; Sarah F Smithson; Karen I Temple; Elisabeth Van Aken; Yolande Van Bever; Jenneke van den Ende; Johanna M Van Hagen; Leopoldo Zelante; Riina Zordania; Anne De Paepe; Bart P Leroy; Marc De Buyzere; Paul J Coucke; Geert R Mortier
Journal:  Eur J Hum Genet       Date:  2010-02-24       Impact factor: 4.246

6.  The phenotypic spectrum in patients with arginine to cysteine mutations in the COL2A1 gene.

Authors:  K P Hoornaert; C Dewinter; I Vereecke; F A Beemer; W Courtens; A Fryer; H Fryssira; M Lees; A Müllner-Eidenböck; D L Rimoin; L Siderius; A Superti-Furga; K Temple; P J Willems; A Zankl; C Zweier; A De Paepe; P Coucke; G R Mortier
Journal:  J Med Genet       Date:  2005-09-09       Impact factor: 6.318

7.  Hypochondrogenesis.

Authors:  Marco Castori; Francesco Brancati; Alessandro Castriota Scanderbeg; Bruno Dallapiccola
Journal:  Pediatr Radiol       Date:  2006-01-24

8.  Loss of DDRGK1 modulates SOX9 ubiquitination in spondyloepimetaphyseal dysplasia.

Authors:  Adetutu T Egunsola; Yangjin Bae; Ming-Ming Jiang; David S Liu; Yuqing Chen-Evenson; Terry Bertin; Shan Chen; James T Lu; Lisette Nevarez; Nurit Magal; Annick Raas-Rothschild; Eric C Swindell; Daniel H Cohn; Richard A Gibbs; Philippe M Campeau; Mordechai Shohat; Brendan H Lee
Journal:  J Clin Invest       Date:  2017-03-06       Impact factor: 14.808

9.  The deletion of six amino acids at the C-terminus of the alpha 1 (II) chain causes overmodification of type II and type XI collagen: further evidence for the association between small deletions in COL2A1 and Kniest dysplasia.

Authors:  A Winterpacht; A Superti-Furga; U Schwarze; H Stöss; B Steinmann; J Spranger; B Zabel
Journal:  J Med Genet       Date:  1996-08       Impact factor: 6.318

10.  Kniest dysplasia is caused by dominant collagen II (COL2A1) mutations: parental somatic mosaicism manifesting as Stickler phenotype and mild spondyloepiphyseal dysplasia.

Authors:  J Spranger; H Menger; S Mundlos; A Winterpacht; B Zabel
Journal:  Pediatr Radiol       Date:  1994
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.